The problems that have impeded progress and growth in the field are still there. I indicated earlier, I'm a little more optimistic perhaps than some with respect to reimbursement because I'm hoping that existing legislation is not going to be the be-all and end-all of that issue. Trending in Congress presently are a number of pieces of legislation intended to encourage growth in telemedicine, in fact, and to support it more richly than has been the case in the past. To persuade the CBO (Congressional Budget Office) to score telemedicine bills more favorably, an effort is underway now to assemble the literature to demonstrate that telemedicine is no worse than budgetneutral, and that because encounters are comparatively inexpensive, it may well be budget-positive.
We still have all the legal issues that we've always had.
Privacy, I think, is going to be more complicated in the future rather than less because big data are becoming such a big deal. And with the Internet-of-Things, and robots, and remote patient monitoring, the amount of data being generated is going to grow dramatically-not all of which is subject to HIPPA (Health Insurance Portability and Accountability Act of 1996), whose applicability is limited.
I suspect that the FTC (Federal Trade Commission) will play a larger role in the privacy arena than it has to date. I also suspect there will be fights over ownership of data, which will grow more valuable as they grow more abundant.
There's a lot going on in the States, and I think we're seeing diminishing geographic restrictions in a lot of the states. We've got parity now in something like 31 states. claims from a failure to respond, or at least respond timely, to signals from remote sensing devices. And there will be some interesting product liability possibilities because interoperability remains such a big problem, and, of course, perpetually.
licensure.
All those things are there. All of them have been addressed to one extent or another.
They still afflict us, but I don't think they will retard us, at least, indefinitely.
Effect of Emerging Technologies in Telehealth
David Gruber:
Has telehealth been proven as a cost-effective technology?
Joel Reich [04:40]
We've seen that technology works. A lot of the studies out there have had small numbers of patients, maybe not long enough, but they've shown it works. You can help people safely stay at home.
The other realm though is the direct provider-to-consumer, which of course I'm sure everywhere you are from around the country affects the major insurers. The major employers want them to have set up $49 call-in for your teleconsult. But that's raising a lot of issues and a lot of questions. It goes right against all the efforts to capture all of your clinical data in one place because now you are collecting in a totally different system. You're also now interspersing different physicians to take care of primary care.
Last week in a health affairs publication, they looked at patients who had upper respiratory infections, who called the $49 telehealth line, and actually had an increase in healthcare spending, probably because they added discretionary visits and didn't actually replace something. So, again, that's not the be-all answer. They didn't look at preventing people from getting sick or being more expensive. But I think we're going to see a turn, and it's beginning to happen, and that is to take the proven technology platforms but use local primary care physicians within the same network in the same 1758. Gruber. Reconfiguration. https://doi.org/10.30953/tmt.v2.38
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I believe that has to happen if we're going to be consistent with everything else we are trying to do, which is as much as you can, connect the data. And I don't think we'll get to full interoperability ever because it goes against a lot of the marketing interests of health systems. But I think that in this area we are going to see much more of we will help you set up the technology platform for your group of local regional physicians and perhaps use the distance consultation by specialists that are not available in your system. That is still a big plus. I think the evidence for COPD, for example, is a little less robust and less well established, but there have been some helpful recent papers that suggest maybe that's changing.
Provider and Caregiver Perspectives
I've been impressed too by the value in the home telehealth setting of the availability of a service for the benefit of caregivers as opposed to the patients themselves. I think it
was Michael Mann who referred to the sandwich generation. Distance care may help folks who are dealing with parents who have had strokes, or suffer from dementia, or are requiring palliative care. There are pretty good data suggesting that the caregivers benefit from the availability of telehealth and distance care technologies. I think that that is hard to quantify: it's hard to put a dollar value on it. But it's also hard to overlook the importance that such support provides to people who frankly could otherwise be overwhelmed.
Return on Investment

David Gruber
How should we think about home telehealth ROI (return on investment)? The utilization has been less than expected given the potential benefits Joe your thoughts please.
